Consensus Guidelines for the Use of Vosoritide in Children with Achondroplasia in Australia.

These recommendations have been developed for healthcare professionals and institutions that are engaged in using vosoritide in the management of achondroplasia and will be revised using a formal framework for clinical guideline development once more evidence is available.